Cargando…
No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli
BACKGROUND: Antibiotic resistance continues to rise due to the increased number of antibiotic prescriptions and is now a major threat to public health. In particular, there is an increase in antibiotic resistance to Escherichia coli according to the latest reports. TRIAL DESIGN: This article examine...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504523/ https://www.ncbi.nlm.nih.gov/pubmed/26107669 http://dx.doi.org/10.1097/MD.0000000000001020 |
_version_ | 1782381475934502912 |
---|---|
author | Yayan, Josef Ghebremedhin, Beniam Rasche, Kurt |
author_facet | Yayan, Josef Ghebremedhin, Beniam Rasche, Kurt |
author_sort | Yayan, Josef |
collection | PubMed |
description | BACKGROUND: Antibiotic resistance continues to rise due to the increased number of antibiotic prescriptions and is now a major threat to public health. In particular, there is an increase in antibiotic resistance to Escherichia coli according to the latest reports. TRIAL DESIGN: This article examines, retrospectively, antibiotic resistance in patients with community- and nosocomial-acquired pneumonia caused by E coli. METHODS: The data of all patients with community- and nosocomial-acquired pneumonia caused by E coli were collected from the hospital charts at the HELIOS Clinic, Witten/Herdecke University, Wuppertal, Germany, within the study period 2004 to 2014. An antibiogram was performed for the study patients with pneumonia caused by E coli. Antimicrobial susceptibility testing was performed for the different antibiotics that have been consistently used in the treatment of patients with pneumonia caused by E coli. All demographic, clinical, and laboratory data of all of the patients with pneumonia caused by E coli were collected from the patients’ records. RESULTS: During the study period of January 1, 2004 to August 12, 2014, 135 patients were identified with community- and nosocomial-acquired pneumonia affected by E coli. These patients had a mean age of 72.5 ± 11.6 (92 [68.1%, 95% CI 60.2%–76.0%] males and 43 [31.9%, 95% CI 24.0%–39.8%] females). E coli had a high resistance rate to ampicillin (60.7%), piperacillin (56.3%), ampicillin–sulbactam (44.4%), and co-trimoxazole (25.9%). No patients with pneumonia caused by E coli showed resistance to imipenem (P < 0.0001). CONCLUSION: E coli was resistant to many of the typically used antibiotics. No resistance was detected toward imipenem in patients with pneumonia caused by E coli. |
format | Online Article Text |
id | pubmed-4504523 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-45045232015-08-05 No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli Yayan, Josef Ghebremedhin, Beniam Rasche, Kurt Medicine (Baltimore) 4900 BACKGROUND: Antibiotic resistance continues to rise due to the increased number of antibiotic prescriptions and is now a major threat to public health. In particular, there is an increase in antibiotic resistance to Escherichia coli according to the latest reports. TRIAL DESIGN: This article examines, retrospectively, antibiotic resistance in patients with community- and nosocomial-acquired pneumonia caused by E coli. METHODS: The data of all patients with community- and nosocomial-acquired pneumonia caused by E coli were collected from the hospital charts at the HELIOS Clinic, Witten/Herdecke University, Wuppertal, Germany, within the study period 2004 to 2014. An antibiogram was performed for the study patients with pneumonia caused by E coli. Antimicrobial susceptibility testing was performed for the different antibiotics that have been consistently used in the treatment of patients with pneumonia caused by E coli. All demographic, clinical, and laboratory data of all of the patients with pneumonia caused by E coli were collected from the patients’ records. RESULTS: During the study period of January 1, 2004 to August 12, 2014, 135 patients were identified with community- and nosocomial-acquired pneumonia affected by E coli. These patients had a mean age of 72.5 ± 11.6 (92 [68.1%, 95% CI 60.2%–76.0%] males and 43 [31.9%, 95% CI 24.0%–39.8%] females). E coli had a high resistance rate to ampicillin (60.7%), piperacillin (56.3%), ampicillin–sulbactam (44.4%), and co-trimoxazole (25.9%). No patients with pneumonia caused by E coli showed resistance to imipenem (P < 0.0001). CONCLUSION: E coli was resistant to many of the typically used antibiotics. No resistance was detected toward imipenem in patients with pneumonia caused by E coli. Wolters Kluwer Health 2015-06-26 /pmc/articles/PMC4504523/ /pubmed/26107669 http://dx.doi.org/10.1097/MD.0000000000001020 Text en Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 4900 Yayan, Josef Ghebremedhin, Beniam Rasche, Kurt No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli |
title | No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli |
title_full | No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli |
title_fullStr | No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli |
title_full_unstemmed | No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli |
title_short | No Development of Imipenem Resistance in Pneumonia Caused by Escherichia coli |
title_sort | no development of imipenem resistance in pneumonia caused by escherichia coli |
topic | 4900 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504523/ https://www.ncbi.nlm.nih.gov/pubmed/26107669 http://dx.doi.org/10.1097/MD.0000000000001020 |
work_keys_str_mv | AT yayanjosef nodevelopmentofimipenemresistanceinpneumoniacausedbyescherichiacoli AT ghebremedhinbeniam nodevelopmentofimipenemresistanceinpneumoniacausedbyescherichiacoli AT raschekurt nodevelopmentofimipenemresistanceinpneumoniacausedbyescherichiacoli |